Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall
Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID
Presentations:
High Mortality of Cytomegalovirus (CMV) Pneumonia in Hematopietic Cell Transplant Recipients
Marjorie Batista, MD, PhD;
Fareed Khawaja, MD;
Annette Artau, MD;
Samuel L. Aitken, PharmD;
Lynn El Haddad, PhD;
Shashank S. Ghantoji, MD, PhD, MPH;
Roy F. Chemaly, MD, MPH, FIDSA, FACP
The More Resistant, the More Fatal: Results of 414 Bacteremia Episodes in Febril Neutropenic Patients
Serkan Surme, MD;
Yusuf E. Ozdemir, MD;
Meryem Sahin, MD;
Ilker I. Balkan, Assoc Prof;
Bilgul Mete, MD;
Gunay Can, Prof;
Fehmi Tabak, Prof;
Nese Saltoglu, Prof Dr, MD
Gram-negative Bacteremia in Neutropenic Patients: Risk Factors for Mortality in the Era of Multiresistance
Fabián Herrera, MD;
Ana Laborde, MD;
Rosana Jordán, MD;
Inés Roccia Rossi, MD;
Graciela Guerrini, MD;
Alejandra Valledor, Infectious Diseases Specialist;
Patricia Costantini, MD;
Miguel Dictar, MD;
Andrea Nenna, MD;
Juan Pablo Caeiro, MD;
Diego Torres, MD;
María Luz Gonzalez Ibañez, MD;
Victoria Pinoni, MD;
Facundo Argüello, MD;
Martín Luck, MD;
Agustina Racioppi, MD;
Fernando Poletta, PhD;
Alberto Carena, MD
Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia after Chemotherapy in Patients with Cancer: The CSRFENCE Score
Theis Aagaard, MD;
Joanne Reekie, MPhil, PhD;
Ashley Roen, MA;
Gedske Daugaard, MD, DMSc, Professor;
Henrik Sengeløv, MD;
Lena Specht, MD, DMSc;
Amanda Mocroft, MSc, Professor;
Jens Lundgren, MD, DMSc, Professor;
Marie Helleberg, MD, PhD, DMSc
The impact of recurrent CMV disease on long-term survival in solid organ transplant recipients
Bradley Gardiner, MBBS, FRACP, MS;
Jennifer Chow, MD, MS;
Sam Brilleman, BSc, MSc Med Stat;
Anton Peleg, MBBS PhD MPH;
David Snydman, MD, FIDSA
Reactivation of Varicella Zoster Virus in Solid Organ Transplant Recipients: Identification of Risk Factors Using Data Mining Tools
Ashley Wallace, BS;
Nicolas Barros, MD;
Donglu Xie, MS;
Christina Yek, MD;
Terrence Liu, BS;
Xilong Li, PhD;
Beverley Adams-Huet, MS;
Robert W. Haley, MD, FSHEA;
David Greenberg, MD;
Ricardo La Hoz, MD, FACP, FAST
Commensal Neisseria Species as a Cause of Disease in Patients Taking Eculizumab
Page Crew, PharmD, MPH;
Lucy McNamara, PhD, MS;
Peter Waldron, MD;
Lynda McCulley, PharmD;
S. Christopher Jones, PharmD, MS, MPH;
Susan Bersoff-Matcha, MD
Hematopoietic Cell Transplantation with Post-transplant Cyclophosphamide: Impact of Donor Type on Pre-engraftment Blood-stream Infections
Chiara Oltolini, MD;
Raffaella Greco, MD;
Laura Galli, MD;
Francesca Lorentino, MD;
Elisabetta Xue, MD;
Maria Teresa Lupo Stanghellini, MD;
Daniela Clerici, MD;
Fabio Giglio, MD;
Jacopo Peccatori, MD;
Massimo Bernardi, MD;
Consuelo Corti, MD;
Paolo Scarpellini, MD;
Antonella Castagna, Prof;
Fabio Ciceri, Prof
Clinical Presentation of BK virus-associated hemorrhagic cystitis (HC) after hematopoietic cell transplantation (HCT)
Hannah Imlay, MD;
Hu Xie, MSc;
Wendy Leisenring, ScD;
Louise Kimball, PhD;
Steven Pergam, MD, MPH, FIDSA;
Ajit Limaye, MD, FIDSA;
Michael Boeckh, MD, PhD, FIDSA
Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
Annette Artau, MD;
Samuel L. Aitken, PharmD;
Marjorie Batista, MD, PhD;
Firas El Chaer, MD;
Amrita Prayag, MD;
Lynn El Haddad, PhD;
Victor Mulanovich, MD;
Ella Ariza-Heredia, MD;
Roy Chemaly, MD, MPH
Lower Rates of Epstein-Barr Virus (EBV) Viremia in Pediatric Solid Organ Transplant (SOT) Recipients Who Received Valganciclovir Prophylaxis
Elizabeth A Moulton, MD, PhD;
Manjiree Karandikar, MD, MBS;
Sheila Bond, MD;
Sandra Burchett, MD, MS;
Tanvi Sharma, MD, MPH;
Francisco M Marty, MD
Is primary CMV infection post-transplant influenced by circadian rhythms?
Hannah Rafferty, BA (Hons), BMBCh;
Jerry Tam, MB BChir PhD;
Colette Smith, PhD;
Matthew Reeves, PhD;
Jane McKeating, PhD;
Dinesh Sharma, MBBS, MS, FRCSEd, FRCS (GENSURG);
David Whitmore, PhD;
Paul Griffiths, MD, DSc
Implementation of a Standard Diet Regimen for Neutropenic High Risk Cancer Patients: Effects on Incidence of Infections, Foodborne Diseases, and Outcome
Carolin Jakob, M. Sc.;
Annika Y. Löhnert, MD;
Melanie Stecher, MSc. Public Health;
Andreas Engert, Prof. Dr. med.;
Meike Freund, MD;
Axel Hamprecht, MD;
Nathalie Jazmati, MD;
Hilmar Wisplinghoff, MD;
Michael Hallek, Prof. Dr. med.;
Oliver A. Cornely, MD;
Janne Vehreschild, Prof. Dr. med.
Incidence, Risk Factors, and Impact of Antiviral Prophylaxis Duration on Cytomegalovirus [CMV] Disease in High-Risk Donor Seropositive/Recipient Seronegative [D+R-] Orthotopic Heart Transplant Recipients [OHTR]
Allison Dumitriu Carcoana, B.A. candidate;
Hannah Imlay, MD;
Cynthia Fisher, MD, MPH;
Beatrice Wong, PharmD;
Robert Rakita, MD;
Ajit Limaye, MD, FIDSA
Conjugate Pneumococcal Vaccination Reduces Invasive Pneumococcal Disease Post Haemotopoietic Stem Cell Transplant
Matthew B Roberts, MBBS, MPH&TM;
Devendra K Hiwase, MBBS, MD, PhD, FRACP, FRCPA;
Narin Bak, MBBS, FRACP, MPH
Clinical Validation of a Novel ELISpot-based in vitro Diagnostic Assay to Monitor CMV-specific Cell-mediated Immunity in SOT and HSCT Immunocompromised Patients
Bernhard Banas, MD;
Dominik Steubl, MD;
Lutz Renders, MD;
Dominik Chittka, MD;
Miriam Banas, MD;
Thomas Wekerle, MD;
Martina Koch, MD;
Oliver Witzke, MD;
Monika Lindemann, MD;
Anja Muehlfeld, MD;
Claudia Sommerer, MD;
Antja Habicht, MD;
Christian Hugo, MD;
Thomas Huenig, MD;
Stephan Mielke, MD;
Martin Schreder, MD;
Eva Wagner, MD;
Daniel Teschner, MD;
Stefan Klein, MD;
Daniela Heidenreich, MD;
Sebastian Kreil, MD;
Kerstin Schaefer-Eckart, MD;
Johannes Gaertner, MD;
Mareike Verbeek, MD;
Sandra Grass, MD;
Christine Wolschke, MD;
Dietlinde Janson, MD;
Guido Kobbe, MD;
Mustafa Kondakci, MD;
Markus Ditschkowski, MD;
Tanja Gromke, MD;
Inken Hilgendorf, MD;
Marie Von Lilienfeld-Toal, MD;
Traudel Schmidt, PhD;
Anne Rascle, PhD;
Sascha Barabas, PhD;
Ludwig Deml, PhD;
Ralf Wagner, PhD;
Bernhard Kraemer, MD;
Bernd Krueger, MD;
Daniel Wolff, MD
Risk of Clinical Tuberculosis (TB) among Patients with Latent TB Infection (LTBI) who Undergo Allogeneic Hematopoietic-Cell Transplantation (HCT).
Amanda E. Kusztos, BS;
Matthew P. Cheng, MD;
Tyler D. Bold, MD, PhD;
Vincent T. Ho, MD;
Brett E. Glotzbecker, MD;
Candace Hsieh, RN, CIC;
Meghan A. Baker, MD;
Sarah P. Hammond, MD;
Lindsey R. Baden, MD;
Francisco M. Marty, MD
Evaluation of MATCH: an Electronic Individual Patient-Focused Management System Aimed at Preventing Cytomegalovirus Disease Following Solid Organ Transplantation
Christina Ekenberg, MD;
Caspar Da Cunha-Bang, MD;
Isabelle Paula Lodding, MD;
Søren Schwartz Sørensen, MD;
Henrik Sengeløv, MD;
Michael Perch, MD;
Allan Rasmussen, MD;
Finn Gustafsson, MD;
Neval Ete Wareham, MD;
Nikolai Kirkby, MSc;
Jesper Kjær, MSc;
Marie Helleberg, MD;
Jens D Lundgren, MD
Impact of Colonization with Fluoroquinolone-Resistant Enterobacteriaceae on the Risk of Gram-Negative Bacteremia in Hematopoietic Stem Cell Transplant Recipients Who Receive Prophylactic Levofloxacin
Michael J. Satlin, MD, MS;
Claire Douglass, BS;
Michael Hovan, BS;
Rosemary Soave, MD, FIDSA;
Anna Chan, MLS;
Tsiporah B. Shore, MD;
Koen Van Besien, MD, PhD;
Sebastian Mayer, MD;
Adrienne A. Phillips, MD, MPH;
Jing-Mei Hsu, MD, PhD;
Rianna Malherbe, BS;
Stephen G. Jenkins, PhD;
Barry N. Kreiswirth, PhD;
Lars F. Westblade, PhD;
Thomas J. Walsh, MD, PhD
The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
Fareed Khawaja, MD;
Terri Lynn Shigle, PharmD, BCPS, BCOP;
Shashank S. Ghantoji, MD, PhD, MPH;
Marjorie Batista, MD, PhD;
Ella Ariza-Heredia, MD;
Roy F. Chemaly, MD, MPH, FIDSA, FACP
Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next Generation Sequencing
Isabelle Paula Lodding, MD;
Mette Jørgensen, PhD;
Marc Bennedbæk, MSc. Engineering;
Nikolai Kirkby, MSc;
Klaudia Naegele, MSc.;
Finn Gustafsson, MD;
Michael Perch, MD;
Allan Rasmussen, MD;
Henrik Sengeløv, MD;
Søren Schwartz Sørensen, MD;
Hans Hirsch, MD;
Jens D Lundgren, MD
BLOODSTREAM INFECTION SURVEY in HIGH-RISK ONCOLOGY PATIENTS (BISHOP) with FEVER AND NEUTROPENIA (FN): Correlation between Initial Empiric Antibiotic Regimen Correlation and Susceptibility Patterns
Andrea Zimmer, MD;
Alison G. Freifeld, MD;
Christopher Arnold, MD;
John W. Baddley, MD;
Pranatharthi Chandrasekar, MD;
Zeinab El Boghdadly, MBBCh;
Carlos Gomez, MD;
Eileen K. Maziarz, MD;
Steven Pergam, MD, MPH, FIDSA;
Kenneth V. Rolston, MD;
Gowri Satyanarayana, MD;
Shmuel Shoham, MD;
Lynne Strasfeld, MD;
Randy Taplitz, MD;
Thomas J. Walsh, MD, PhD;
Jo-Anne Young, MD;
Jane Meza, PhD;
Yuning Zhang, Ph.D
Prevalence and Significance of Pre-Transplant BK Viremia and Viruria in Deceased and Living Kidney Donors and Kidney Transplant Recipients
Susanna K. Tan, MD;
Malaya K. Sahoo, PhD;
ChunHong Huang, PhD;
Jenna Weber, BS;
Jason Kurzer, MD, PhD;
Waldo Concepcion, MD;
Peter Chin-Hong, MD;
Aruna Subramanian, MD, FIDSA;
Jane Tan, MD;
Benjamin Pinksy, MD, PhD
Analysis of Breakthrough Blood Stream Infections in Left Ventricular Assist Device Recipients Managed with Chronic Antimicrobial Suppressive Therapy
Deeksha Jandhyala, M.D.;
John C O'horo, MD;
Alan J. Wright, MD, FIDSA, FSHEA;
Randall C. Walker, MD;
John Stulak, MD;
Andres Bran, MD;
Larry M Baddour, MD;
Saira Farid, MD;
M Rizwan Sohail, MD
Clinical Prediction Tool for Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae as the Etiology of Bacteremia in Solid Organ Transplant Recipients
Rebecca Wang, MD;
Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA;
Jennifer Han, MD, MSCE;
Emily Blumberg, MD, FIDSA;
Pranita Tamma, MD, MHS;
Kerri Thom, MD;
Kevin Alby, PhD;
Warren Bilker, PhD;
Jacqueline Omorogbe, BS;
Pam Tolomeo, MPH;
Judith Anesi, MD
Increased Detection of Diarrheal Pathogens in Hematopoietic Stem Cell Transplant Recipients using a Multiplexed PCR Panel
Wesley Rogers, BA;
Lars Westblade, PhD;
Stephen G Jenkins, PhD;
Koen Van Besien, MD, PhD;
Harjot Singh, MD, ScM;
Rosemary Soave, MD, FIDSA;
Carl Crawford, MD;
Michael Satlin, MD, MS
Impact of levofloxacin for the prophylaxis of bloodstream infection on the gut microbiome in patients with hematologic malignancy
Matthew Ziegler, MD;
Jennifer H. Han, MD, MSCE;
Daniel Landsburg, MD;
David Pegues, MD, FIDSA, FSHEA;
Emily Reesey, MS;
Cheryl Gilmar, MS, MT, CIC;
Theresa Gorman, MSN, RN, AOCNS;
Kristen Bink, MSN, RN, AGCNS-BC;
Amy Moore, MSN, RN, ACNS-BC;
Brendan J. Kelly, MD, MS
Thinking Locally: Can Unit-Specific Methicillin-Resistant Staphylococcus aureus Screening Augment Stewardship Interventions for Febrile Neutropenia?
Rachel Bartash, MD;
Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA;
Adam Binder, MD;
Kelsie Cowman, MPH;
Carol Sheridan, RN MSN OCN BMTCN;
Yi Guo, PharmD;
Michael Levi, ScD, (D) ABMM;
Wendy Szymczak, PhD;
Philip Gialanella, MS;
Priya Nori, MD
Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients
Mark Poulsen Khurana, Medical Student;
Isabelle Paula Lodding, MD;
Amanda Mocroft, MSc, Professor;
Søren Schwartz Sørensen, MD;
Michael Perch, MD;
Allan Rasmussen, MD;
Finn Gustafsson, MD;
Jens Lundgren, MD, DMSc, Professor
Oral step down therapy with levofloxacin for low risk febrile neutropenia in children
Sonia Mehra, MD;
Jared A Olson, PharmD;
Adam L. Hersh, MD, PhD;
Emily Thorell, MD, MSCI;
Richard Lemons, MD;
Andrew Pavia, MD, FIDSA, FSHEA, FPIDS;
Elizabeth Knackstedt, MD
Rejection Outcomes in Lung Transplant Recipients Post Respiratory Syncytial Virus Infections
Nitipong Permpalung, MD, MPH;
Tany Thaniyavarn, MD;
Jennifer Saullo, MD, PharmD;
Sana Arif, MBBS;
Rachel Miller, MD;
John Reynolds, MD;
Barbara D. Alexander, MD, MHS
An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach
Nitipong Permpalung, MD, MPH;
Tany Thaniyavarn, MD;
Jennifer Saullo, MD, PharmD;
Sana Arif, MBBS;
Rachel Miller, MD;
John Reynolds, MD;
Barbara D. Alexander, MD, MHS, FIDSA
Effect of Preemptive Rituximab Therapy on Epstein-Barr reactivation in Allogenic Hematopoietic Stem Cell Pediatric Transplants
Gaud Catho, MD;
Daniel Scheel, MSc;
Pierre Teira, MD, MSc;
Christian Renaud, MD, MSc, FRCPC;
Lisa Kakinami, PhD;
Philippe Ovetchkine, MD, MSc;
Julie Autmizguine, MD, MSc, FRCPC
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
